13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001823138
Total reported value
$5.0B
$5.0B
26 檔
53.1%
According to the latest 13F quarterly dataset, Two Seas Capital LP managed an equity portfolio of $5.0B at the end of Q1 2025, spanning 26 distinct U.S. exchange-listed positions.
Two Seas Capital LP executed strategic sector rebalancing during Q1 2025, establishing 5 new positions while fully exiting 8 holdings and trimming 6 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 35.86% | -20.29% | +917.50% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 22.53% | — | +666.33% | |
| 3 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-High Yield | 18.21% | — | — | |
| 4 | TLN | Talen Energy CORP | Stock-Utilities | 4.54% | +1.28% | -21.36% | |
| 5 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 3.36% | — | -8.76% | |
| 6 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 3.22% | +3.08% | -0.31% | |
| 7 | CORZ | Core Scientific Inc | Stock-Tech | 2.01% | +3.29% | +41.70% | |
| 8 | VST | Vistra CORP | Stock-Utilities | 1.89% | +0.96% | +34.91% | |
| 9 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 1.22% | — | +15.13% | |
| 10 | SHC | Sotera Health Co | Stock-Other | 1.22% | +0.84% | +14.67% | |
| 11 | CLMT | Calumet Inc | Stock-Other | 1.15% | +1.73% | +31.29% | |
| 12 | ABUS | Arbutus Biopharma CORP | Stock-Other | 1.04% | +0.65% | +8.29% | |
| 13 | IMVT | Immunovant Inc | Stock-Other | 0.88% | +1.29% | +8.68% | |
| 14 | GLNG | Golar LNG Limited | Stock-Energy | 0.62% | +0.30% | — | |
| 15 | TDAY | USA Today Co Inc | Stock-Other | 0.57% | +1.00% | +106.97% | |
| 16 | FTAI | FTAI Aviation Ltd. | Stock-Industrials | 0.40% | +0.45% | — | |
| 17 | ARDX | Ardelyx Inc | Stock-Other | 0.33% | — | +14.28% | |
| 18 | ESPR | Esperion Therapeutics Inc | Stock-Other | 0.31% | -0.44% | EXIT | |
| 19 | SONO | Sonos Inc | Stock-Other | 0.14% | +0.02% | -18.51% | |
| 20 | IREN | IREN Limited | Stock-Other | 0.13% | +0.13% | NEW | |
| 21 | ADAPY | Adaptimmune Therapeutics-adr | Stock-Other | 0.13% | — | +38.39% | |
| 22 | NBIS | Nebius Group N.V. | Stock-Other | 0.10% | -0.28% | EXIT | |
| 23 | HUT | Hut 8 CORP | Stock-Financials | 0.05% | +0.20% | -72.36% | |
| 24 | OMEX | Odyssey Marine Exploration | Stock-Other | 0.03% | +0.02% | — | |
| 25 | CORZW | Core Scientific Inc - 27 | Stock-Other | 0.03% | +0.07% | — | |
| 26 | WULF | Terawulf Inc | Stock-Financials | 0.02% | +1.24% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +25.7% | +917.50% | Add |
| 2 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | +18.2% | NEW | New buy |
| 3 | QQQ | Invesco Qqq Trust Series 1 | +13.7% | +666.33% | Add |
| 4 | GLNG | Golar LNG Limited | +0.6% | NEW | New buy |
| 5 | FTAI | FTAI Aviation Ltd. | +0.4% | NEW | New buy |
| 6 | NBIS | Nebius Group N.V. | +0.1% | NEW | New buy |
| 7 | WULF | Terawulf Inc | 0% | NEW | New buy |
| 8 | OMEX | Odyssey Marine Exploration | -0.1% | — | Unchanged |
| 9 | ✓ | Bit Digital Inc | -0.2% | EXIT | Sold out |
| 10 | CORZW | Core Scientific Inc - 27 | -0.2% | — | Unchanged |
| 11 | SOC | Sable Offshore CORP | -0.3% | EXIT | Sold out |
| 12 | GOOGL | Alphabet Inc-cl A | -0.4% | EXIT | Sold out |
| 13 | APLD | Applied Digital CORP | -0.4% | EXIT | Sold out |
| 14 | ESPR 4 11-15-25Bond | Esperion Therapeutics | -0.5% | EXIT | Sold out |
| 15 | ARDX | Ardelyx Inc | -0.5% | +14.28% | Add |
| 16 | SONO | Sonos Inc | -0.6% | -18.51% | Trim |
| 17 | ADAPY | Adaptimmune Therapeutics-adr | -0.6% | +38.39% | Add |
| 18 | IREN | IREN Limited | -0.6% | -22.67% | Trim |
| 19 | TDAY | USA Today Co Inc | -0.8% | +106.97% | Add |
| 20 | HUT | Hut 8 CORP | -0.8% | -72.36% | Trim |
| 21 | ✓ | Bitdeer Technologies Group | -0.8% | EXIT | Sold out |
| 22 | ESPR | Esperion Therapeutics Inc | -0.9% | +11.23% | Add |
| 23 | META | Meta Platforms Inc-class A | -0.9% | EXIT | Sold out |
| 24 | ABUS | Arbutus Biopharma CORP | -1.4% | +8.29% | Add |
| 25 | CEG | Constellation Energy | -1.9% | EXIT | Sold out |
| 26 | SHC | Sotera Health Co | -2.2% | +14.67% | Add |
| 27 | IMVT | Immunovant Inc | -2.4% | +8.68% | Add |
| 28 | VST | Vistra CORP | -2.6% | +34.91% | Add |
| 29 | ✓ | Avadel Pharmaceuticals PLC ADR | -2.7% | +15.13% | Add |
| 30 | CLMT | Calumet Inc | -3% | +31.29% | Add |
| 31 | CORZ | Core Scientific Inc | -5.6% | +41.70% | Add |
| 32 | ROIV | Roivant Sciences Ltd. | -7.2% | -0.31% | Trim |
| 33 | INDV | Indivior Pharmaceuticals, Inc. | -10% | -8.76% | Trim |
| 34 | TLN | Talen Energy CORP | -11.5% | -21.36% | Trim |
According to official SEC Form 13F filings, Two Seas Capital LP reported a total U.S. public equity portfolio value of $5.0B across 26 disclosed positions in Q1 2025.
During Q1 2025, Two Seas Capital LP's top holdings by market value included SPY (35.9%)、QQQ (22.5%)、HYG (18.2%). The largest single position, SPY, represented 35.9% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, QQQ, HYG) accounted for 53.1% of total reported equity market value during Q1 2025.
Top New Position Initiated
HYG
市值: $577.9M
Top Position Liquidated / Trimmed
CEG
前期市值: $22.0M
In Q1 2025, Two Seas Capital LP made 32 total portfolio adjustments, initiating 5 new buys, adding to 13 positions, trimming 6 holdings, and fully liquidating 8 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.